Kidney Neoplasms: all 973 studies

Page 4 of 10. Open to participants first (214), then studies with results posted, then the rest; newest registration first within each.

• Dose Dense MVAC for Muscle Invasive Bladder CancerCompletedNCT01031420Phase 2Results posted
• Study of Pazopanib and Ixabepilone in Patients With Solid TumorsTerminatedNCT01012362Phase 1Results posted
• A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)TerminatedNCT00960063Phase 1Results posted
• Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell CancerCompletedNCT00920816Phase 3Results posted
• Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum CalciumCompletedNCT00896454Phase 2Results posted
• Sorafenib in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Sunitinib or BevacizumabCompletedNCT00866320Phase 2Results posted
• Safety and Toxicity Study of Sorafenib in Patients With Kidney CancerCompletedNCT00854620Phase 2Results posted
• Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney CancerTerminatedNCT00853125Phase 2Results posted
• Bevacizumab and Aldesleukin in Treating Patients With Metastatic Clear Cell Carcinoma of the KidneyCompletedNCT00853021Phase 2Results posted
• Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney CancerCompletedNCT00849186Not applicableResults posted
• Everolimus (RAD001) For Advanced Renal Cell Carcinoma (RCC) Before Kidney RemovalTerminatedNCT00831480Phase 2Results posted
• Biomarker Trial of Everolimus in Patients With Advanced Renal Cell CarcinomaCompletedNCT00827359Phase 2Results posted
• Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell CarcinomaCompletedNCT00782275Phase 2Results posted
• Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial CancerCompletedNCT00749892Phase 2Results posted
• Study of IMO-2055 in Metastatic or Locally Recurrent Clear Cell Renal CarcinomaCompletedNCT00729053Phase 2Results posted
• Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney CancerTerminatedNCT00727532Not applicableResults posted
• Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic CancerTerminatedNCT00704938Phase 2Results posted
• RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in EuropeCompletedNCT00688753Phase 2Results posted
• Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell CancerCompletedNCT00678392Phase 3Results posted
• Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RAD001 (Everolimus)TerminatedNCT00651482Phase 2Results posted
• Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-AntibodyCompletedNCT00606632Phase 3Results posted
• Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney CancerTerminatedNCT00601926Phase 2Results posted
• PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney CancerTerminatedNCT00589550Phase 1Results posted
• Study of IL2 in Combination With Zoledronic Acid in Patients With Kidney CancerTerminatedNCT00582790Phase 2Results posted
• Phase II Study of Vandetanib in Individuals With Kidney CancerCompletedNCT00566995Phase 2Results posted
• Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the BrainTerminatedNCT00550654Phase 2Results posted
• LBH589 Treatment for Refractory Clear Cell Renal CarcinomaCompletedNCT00550277Phase 2Results posted
• Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone MetastasesTerminatedNCT00540969Phase 3Results posted
• Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRICompletedNCT00537056Not applicableResults posted
• Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or LymphomaCompletedNCT00531284Phase 1/2Results posted
• Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung CancerCompletedNCT00514215Phase 2Results posted
• Sorafenib in Treating Patients With Metastatic or Unresectable Kidney CancerTerminatedNCT00496756Phase 2Results posted
• Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell CarcinomaCompletedNCT00496587Phase 2Results posted
• Zoledronate With Atorvastatin in Renal Cell CarcinomaCompletedNCT00490698Phase 2Results posted
• Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney FunctionCompletedNCT00478361Phase 2Results posted
• Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney CancerTerminatedNCT00467077Phase 2Results posted
• Sunitinib Malate in Patients With Non-Clear Cell Renal Cell CancerCompletedNCT00465179Phase 2Results posted
• Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or MelanomaCompletedNCT00462982Phase 2Results posted
• Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by SurgeryCompletedNCT00459979Phase 2Results posted
• Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney CancerCompletedNCT00459875Phase 2Results posted
• Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSFCompletedNCT00458536Phase 1/2Results posted
• Radiosurgery in Treating Patients With Kidney TumorsCompletedNCT00458484Not applicableResults posted
• High-dose Bevacizumab in Advanced Renal Carcinoma PatientsCompletedNCT00455975Phase 2Results posted
• A Study of MDX-1106 in Patients With Selected Refractory or Relapsed MalignanciesCompletedNCT00441337Phase 1Results posted
• Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney CancerCompletedNCT00425386Phase 2Results posted
• VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the UrotheliumCompletedNCT00407485Phase 2Results posted
• Lenalidomide in Treating Patients With Advanced or Unresectable Kidney CancerCompletedNCT00403169Phase 2Results posted
• Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the UrotheliumCompletedNCT00397488Phase 2Results posted
• Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney CancerCompletedNCT00392821Phase 1/2Results posted
• A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell CancerCompletedNCT00375674Phase 3Results posted
• Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With CancerCompletedNCT00369564Phase 3Results posted
• Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid TumorsCompletedNCT00365768Phase 2Results posted
• Vorinostat in Treating Patients With Locally Recurrent or Metastatic Cancer of the UrotheliumTerminatedNCT00363883Phase 2Results posted
• Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney TumorsCompletedNCT00335556Phase 2Results posted
• Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney CancerCompletedNCT00331409Phase 2Results posted
• Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney CancerCompletedNCT00328861Phase 2Results posted
• Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal CarcinomaCompletedNCT00323739Phase 2Results posted
• Allogeneic Bone Marrow Transplantation Using Less Intensive TherapyTerminatedNCT00303719Phase 2Results posted
• Study Of AG-013736 In Patients With Refractory Metastatic Renal Cell CancerCompletedNCT00282048Phase 2Results posted
• Bortezomib in Treating Patients With Metastatic Kidney CancerCompletedNCT00276614Phase 2Results posted
• Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses.CompletedNCT00199888Phase 1Results posted
• Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250CompletedNCT00199875Phase 1Results posted
• Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney CancerTerminatedNCT00176501Phase 2Results posted
• Phase I/II Dose-escalation Study of Lutetium-177-labeled cG250 in Patients With Advanced Renal CancerCompletedNCT00142415Phase 1/2Results posted
• Neoadjuvant Clinical Trial to Evaluate the Efficacy of Bevacizumab for Renal Cell CarcinomaCompletedNCT00113217Phase 2Results posted
• Sorafenib in Treating Patients With Regional or Metastatic Cancer of the UrotheliumTerminatedNCT00112905Phase 2Results posted
• Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary TractCompletedNCT00112671Phase 2Results posted
• PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney CancerTerminatedNCT00090870Phase 2Results posted
• Vaccine Treatment of Kidney CancerTerminatedNCT00089778Phase 2Results posted
• Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney CancerTerminatedNCT00089102Phase 2Results posted
• 17AAG to Treat Kidney Tumors in Von Hippel-Lindau DiseaseCompletedNCT00088374Phase 2Results posted
• Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney CancerCompletedNCT00087022Phase 3Results posted
• DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCCCompletedNCT00085436Phase 2Results posted
• Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell CarcinomaCompletedNCT00076011Phase 2Results posted
• Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical CancerCompletedNCT00069160Phase 2Results posted
• Study Evaluating Interferon And CCI-779 In Advanced Renal Cell CarcinomaCompletedNCT00065468Phase 3Results posted
• S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the UrotheliumCompletedNCT00045630Phase 2Results posted
• Erlotinib in Treating Patients With Advanced Kidney CancerCompletedNCT00045487Phase 2Results posted
• S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary TractTerminatedNCT00022633Phase 2Results posted
• Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney CancerCompletedNCT00003656Phase 2Results posted
• Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney CancerCompletedNCT00003102Phase 1/2Results posted
• Robotic vs Laparoscopic and Open Surgery for Abdominopelvic CancersCompletedNCT07821775
• Tumor Heterogeneity of Renal Tumors Assessed by Multiparametric MRI With Direct Radiological-histopathological Correlation: an Explorative StudyCompletedNCT07713654Not applicable
• Multimodal Prediction of Postoperative Prognosis After Partial Nephrectomy for Endophytic Renal Cell CarcinomaActive, not recruitingNCT07697417
• Evaluation of 68Ga-PSMA PET-CT in the Initial Staging of Advanced Renal Cell Carcinomas - A Prospective, Multicentre, Open-label StudyWithdrawnNCT07624578Not applicable
• Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3)CompletedNCT07568444Phase 2
• Risk of Scrotal Hydroceles After Nephrectomy For Kidney CancerActive, not recruitingNCT07527637
• Efficacy and Safety of VasoClip® vs. WeckClip® for Robotic Urologic SurgeryCompletedNCT07413120Phase 3
• Navigated Partial NephrectomyCompletedNCT07315100Not applicable
• CD70.CAR for CD70+ Lymphoma, Myeloma and Solid TumorsWithdrawnNCT07297160Phase 1
• A Novel Haemostatic Agent for Robotic Partial NephrectomyWithdrawnNCT07284953Not applicable
• Renal Tumour Imaging Using MRIActive, not recruitingNCT07173140Not applicable
• Piflufolastat F 18 PET/CT in Patients With Suspected, or at High Risk for Metastatic ccRCCWithdrawnNCT07084909Phase 2/3
• Symptomatic and Incidental RCC DetectionCompletedNCT07004426
• A Study to Investigate the Efficacy and Safety of Volrustomig ± Casdatifan vs Nivolumab + Ipilimumab as 1L Treatment for Advanced ccRCCActive, not recruitingNCT07000149Phase 1
• Current Role of Pentafecta Outcomes in Open and Laparoscopic Partial Nephrectomy for Localized Renal TumorsCompletedNCT06969131Not applicable
• 177LuPSMA in Renal Cell CarcinomaActive, not recruitingNCT06964958Phase 2
• Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.CompletedNCT06955910
• Imaging-Guided Classification for Endophytic Renal Tumors: PN Strategies & OutcomesActive, not recruitingNCT06954571
• Robot-assisted Partial Nephrectomy With and Without Mixed Reality (REALITATEM Study)CompletedNCT06903260Phase 3

← Kidney Neoplasms overview